These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3014770)

  • 1. Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil.
    Schatzmayr HG; Maurice Y; Fujita M; de Fillipis AM
    Vaccine; 1986 Jun; 4(2):111-3. PubMed ID: 3014770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new combined inactivated DPT-polio vaccine.
    Drucker J; Soula G; Diallo O; Fabre P
    Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.
    Guérin N; Bregère P; Caudrelier P; Raynaud O
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):815-6. PubMed ID: 9923532
    [No Abstract]   [Full Text] [Related]  

  • 6. The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency.
    Simoes EA; John TJ
    J Biol Stand; 1986 Apr; 14(2):127-31. PubMed ID: 3020057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
    Rümke HC
    Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.
    Cuba IPV Study Collaborative Group
    N Engl J Med; 2007 Apr; 356(15):1536-44. PubMed ID: 17429085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a combined DTP-polio vaccine in a reduced schedule.
    Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Drucker J; Epstein I; Leitner L; Goldblum N
    Dev Biol Stand; 1986; 65():159-66. PubMed ID: 2881820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The level of postvaccinal immunity to diphtheria, tetanus and poliomyelitis in relation to the number of inoculations].
    Chudnaia LM; Oksiiuk VG; Shekhter AB; Krasiuk LS; Afanas'eva SM; Bryzhata SI; Kozhan NE; Chaban EP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):46-9. PubMed ID: 1650072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994.
    Ion-Nedelcu N; Strebel PM; Toma F; Biberi-Moroeanu S; Combiescu M; Persu A; Aubert-Combiescu A; Plotkin SA; Sutter RW
    J Infect Dis; 1997 Feb; 175 Suppl 1():S241-6. PubMed ID: 9203723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity study to investigate the interchangeability among three different types of polio vaccine: A cohort study in Japan.
    Ohfuji S; Ito K; Ishibashi M; Shindo S; Takasaki Y; Yokoyama T; Yokoyama T; Yamashita Y; Shibao K; Nakano T; Tsuru T; Irie S; Hirota Y
    Medicine (Baltimore); 2017 Jun; 96(23):e7073. PubMed ID: 28591046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.